Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of Clin-RA Gel versus clindamycin gel, tretinoin gel, and vehicle for acne vulgaris
2010-022911-20Phase 3
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clindamycin + tretinoin, clindamycin and tretinoin in acne vulgaris (4 arms), sponsored by Dow Pharmaceutical Sciences. Primary endpoint: Co-primary efficacy variables.
02
Drugs
clindamycin + tretinoinclindamycintretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2010-022911-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022911-20.